Heelys receives NASDAQ deficiency letter
Heelys Inc. said it has received a NASDAQ staff deficiency letter that it no longer complies wth NASDAQ's audit committee requirement.
> Nasdaq is warning Oncothyreon that it has to be compliant with capital requirements by September 15 to prevent its move from the Global Market to the Capital Market.